Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6 HKD | -0.33% |
|
+0.67% | -21.47% |
06-05 | 3D Medicines to Appoint New Auditors | MT |
03-29 | 3D Medicines' 2023 Loss Almost Halves as Revenue Jumps 12% | MT |
Sales 2022 | 567.39 4.43K 776.99 | Sales 2023 | 634.95 4.96K 869.5 | Capitalization | 1.57B 12.29B 2.16B |
---|---|---|---|---|---|
Net income 2022 | -1.02B -7.99B -1.4B | Net income 2023 | -525M -4.1B -719M | EV / Sales 2022 | 13,423,339 x |
Net cash position 2022 | 766M 5.98B 1.05B | Net cash position 2023 | 714M 5.57B 978M | EV / Sales 2023 | 1,355,202 x |
P/E ratio 2022 |
-1.67
x | P/E ratio 2023 |
-3.02
x | Employees | 198 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
1 day | -0.33% | ||
1 week | +0.67% | ||
Current month | -6.54% | ||
1 month | -16.43% | ||
3 months | -9.91% | ||
6 months | -17.81% | ||
Current year | -21.47% |
![Extreme 5.69](/images/extremecours_fleche.png)
![Extreme 5.49](/images/extremecours_fleche.png)
![Extreme 5.17](/images/extremecours_fleche.png)
![Extreme 4.68](/images/extremecours_fleche.png)
![Extreme 4.68](/images/extremecours_fleche.png)
![Extreme 4.68](/images/extremecours_fleche.png)
![Extreme 4.68](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Zhao Long Gong
CEO | Chief Executive Officer | 60 | 13-12-31 |
Jing Zhang
DFI | Director of Finance/CFO | 50 | 20-08-27 |
Zhi Qiang Xue
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Tat Pang Lin
BRD | Director/Board Member | 67 | 22-11-30 |
Xin Guang Liu
BRD | Director/Board Member | 63 | 21-06-24 |
Zhao Long Gong
CEO | Chief Executive Officer | 60 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-21 | 6 | -0.33% | 281,000 |
24-06-20 | 6.02 | +2.56% | 556,000 |
24-06-19 | 5.87 | +1.91% | 283,000 |
24-06-18 | 5.76 | -2.21% | 557,000 |
24-06-17 | 5.89 | -1.17% | 355,500 |
Delayed Quote Hong Kong S.E., June 21, 2024 at 04:08 am
More quotes1st Jan change | Capi. | |
---|---|---|
-21.47% | 188M | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- 1244 Stock